Literature DB >> 21030932

Prosthetic sleeve reinforcing for juxtarenal abdominal aortic aneurysm: experience of 30 cases.

Toshinori Totsugawa1, Hidenori Yoshitaka, Masahiko Kuinose, Atsuhisa Ishida, Yoshimasa Tsushima, Genta Chikazawa.   

Abstract

OBJECTIVE: Endovascular repair remains a challenge in the treatment of juxtarenal abdominal aortic aneurysms (AAAs); open surgery is now the treatment of choice. Because the proximal anastomosis involves a fragile aortic wall and renal ischemic time is correlated with postoperative renal dysfunction, simple and secure reinforcing of the suture line is indispensable in juxtarenal AAA repair. Our report describes the efficacy of prosthetic sleeve reinforcing (PSR) for this repair. PATIENTS AND METHODS: From 2005 to 2009, 30 patients, including 4 with ruptured aneurysms, underwent juxtarenal AAA repair with PSR. We reviewed their in-hospital and midterm outcomes.
RESULTS: Mean renal ischemic time was 26 ± 5.5 min. Mean hospital length of stay was 19 days; including 4 cases of ruptured juxtarenal AAA, there were no mortalities. Three patients with preoperative renal dysfunction, including 2 with aneurysmal rupture, required temporary renal replacement therapy. The overall survival rate was 93% (28/30). There was no case of postoperative graft-related complications, including anastomotic pseudoaneurysm and graft-enteric fistula.
CONCLUSION: PSR enables secure and prompt proximal anastomosis, preventing postoperative morbidity and late graft-related complications. We conclude that PSR could be a valuable method for juxtarenal AAA repair.

Entities:  

Mesh:

Year:  2010        PMID: 21030932

Source DB:  PubMed          Journal:  Ann Thorac Cardiovasc Surg        ISSN: 1341-1098            Impact factor:   1.520


  1 in total

1.  Kilt Technique as an Angle Modification Method for Endovascular Repair of Abdominal Aortic Aneurysm with Severe Neck Angle.

Authors:  Tae-Hoon Kim; Ho-Jun Jang; Young Jin Choi; Chang Keun Lee; Sung Woo Kwon; Won-Heum Shim
Journal:  Ann Thorac Cardiovasc Surg       Date:  2017-03-23       Impact factor: 1.520

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.